The Colorectal Cancer Molecular Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Colorectal Cancer Molecular Diagnostics Market?
The global market for colorectal cancer molecular diagnostics has been expanding considerably in the past. The market, which was valued at $2.56 billion in 2024, is expected to reach $2.77 billion in 2025. This represents a compound annual growth rate (CAGR) of 8.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Colorectal Cancer Molecular Diagnostics Industry?
The global market for colorectal cancer molecular diagnostics is predicted to expand to $3.79 billion by 2029, growing at a compound annual growth rate of 8.1%.
Download Your Free Sample of the 2025 Colorectal Cancer Molecular Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Colorectal Cancer Molecular Diagnostics Market?
The key drivers in the colorectal cancer molecular diagnostics market are:
• Aging population and increased risk factors contributing to higher incidences of colorectal cancer
• Integration of genomic data into clinical practice enhancing diagnostic precision
• Rise in precision medicine approaches improving targeted treatment options
• Global efforts in cancer research and collaboration promoting development in diagnostics
Global Market Segmentation: Identifying Major Colorectal Cancer Molecular Diagnostics Industry Segments
The colorectal cancer molecular diagnostics market covered in this report is segmented –
1) By Type: Instruments, Reagents And Kits, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)
3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings
Pre-order the 2025 Colorectal Cancer Molecular Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Colorectal Cancer Molecular Diagnostics Market?
The key trends in the colorectal cancer molecular diagnostics market are:
• There is an increasing emphasis on the early detection biomarkers in the colorectal cancer molecular diagnostics market.
• Integration of artificial intelligence in data analysis is becoming a significant trend.
• The rise of circulating tumor DNA (ctDNA) analysis is shaping the future market dynamics.
• The market is also experiencing an expansion in companion diagnostics for targeted therapies, with a particular focus on immunotherapy biomarkers.
Who Are the Top Competitors & Leading Players in the Colorectal Cancer Molecular Diagnostics Market?
Major companies in the colorectal cancer molecular diagnostics market are:
• Johnson & Johnson
• Bayer AG
• Abbott Laboratories
• Danaher Corporation
• Becton Dickinson and Company
• Biocartis Group NV
• Agilent Technologies Inc.
• Grifols S.A
• Hologic Inc.
• Biomérieux SA
• Quidel Corporation
• Bio-Rad Laboratories Inc.
• Qiagen N.V.
• Exact Sciences Corporation
• Illumina Inc.
• Cepheid
• Myriad Genetics Inc.
• Guardant Health
• Luminex Corporation
• GenMark Diagnostics
• Amoy Diagnostics Co. Ltd.
• MDxHealth Inc.
• HTG Molecular Diagnostics Inc.
• GenPath Diagnostics
• geneOmbio Technologies Pvt.
Regional Dominance: Which Area Leads the Global Colorectal Cancer Molecular Diagnostics Market?
North America was the largest region in the colorectal cancer molecular diagnostics market in 2024
